20% Americans Are Job-Hopping For Ozempic; Is It A Health Win Or A Risky Shortcut?

20% Americans Are Job-Hopping For Ozempic; Is It A Health Win Or A Risky Shortcut?

Credits: Freepik

Text

Updated May 10, 2025 | 02:08 PM IST

SummaryWeight loss drugs like Ozempic and Wegovy, originally for diabetes, are now in high demand as they enable significant fat loss, but come with high costs, side effects, and long-term dependency risks.

End of Article